Whether carbapenemase-producing strains of A cinetobacter spp. are unique to the Q MU H Burns U nit or are more widespread throughout the U K is not currently known, although data from abroad suggest that they are becoming more prevalent. 6 What is not in doubt is that diagnostic laboratories should be aware of the difficulties in identifying them. With regard to our isolates, the disc diffusion method detected reduced susceptibility to meropenem, but not to imipenem. The efficacy of carbapenems as treatment of patients with infections caused by these bacteria is also unclear. A lthough the MICs of both agents, and particularly those of imipenem, are below the susceptibility breakpoint, we have adopted a cautious approach to the use of these drugs and would welcome data regarding clinical response rates in other patient populations. For the treatment of patients infected with such organisms, the therapeutic options at Q MU H include sulbactam/ampicillin and polymyxin, these being the only antibiotics to which the isolates are consistently susceptible.
. MICs for these isolates were determined by the agar dilution method with IsoSensitest agar and inocula of 10 4 cfu per spot. Many of the isolates exhibited low-level resistance, with the MICs of imipenem and meropenem ranging from 2 to 8 mg/L, compared with MICs of 0.12-0.25 mg/L for historical isolates and relative to a MIC breakpoint of 4 mg/L. O ther strains were more resistant, with carbapenem MICs of 16-128 mg/L (Table) . A mongst all these isolates, cross-resistance to penicillins, cephalosporins, aminoglycosides and quinolones was virtually complete.
-Lactamase extracts of the referred strains, which were prepared by sonicating cells harvested from nutrient agar cultures in 0.1 M phosphate buffer pH 7.0, were subjected to isoelectric focusing. In addition, their activities against imipenem and meropenem, at concentrations of 20 mg/L, were evaluated by a biological assay. E ach antibiotic and an extract were incubated together for 1 h before being transferred to wells cut into a bioassay plate containing
Mueller-H inton agar, the surface of which was inoculated with E scherichia coli NCTC 10418 as the indicator organism. The extracts of all of the strains, with the exception of one from H ong Kong, hydrolysed one or both carbapenems (Table) , whereas extracts of the carbapenem-susceptible control strains (MICs 0.25 mg/L) did not do so. The isoelectric points (pIs) of the -lactamases were highly variable, with most extracts yielding multiple bands and with no single band common to all. In several cases, we isolated individual -lactamases by ion-exchange chromatography and identified those with carbapenemase activities. The biochemical characteristics of these enzymes, which also varied from isolate to isolate, will be described in a separate report. A ll of those that have been purified to date (indicated by a in the Table) were inhibited by tazobactam, but not by E D TA , thereby indicating that, unlike most carbapenemases, they are not zinc-dependent. 4, 5 This account of the worldwide emergence of carbapenem resistance amongst A cinetobacter spp. reinforces the concerns expressed by Weinbren et al. 6 who described the persistence of such bacteria over a 1 year period in a U K burns unit. O thers, from A rgentina and South A frica, have also described carbapenem-resistant isolates. 7, 8 Many of these strains were susceptible only to sulbactam, 3, 6 which is not available as a single agent, and to polymyxin, the in-vivo efficacy of which remains unconfirmed.
